CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[Prophylactic Cranial Irradiation Improves Survival in Limited-Stage SCLC]]>

Data ReadoutpositivePositive
AI Analysis

Summary

A real-world CASCADE database analysis shows prophylactic cranial irradiation is associated with a median overall survival of 29.8 months in limited-stage small cell lung cancer. This represents a clinical finding from retrospective data analysis rather than a prospective trial readout.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Prophylactic cranial irradiation associated with median overall survival of 29.8 months in limited-stage SCLC in CASCADE database analysis

Importance:4/10
Sentiment:
0.60
SCLCprophylactic cranial irradiationlimited-stageoverall survivalreal-world analysisCASCADE database

Read the original article

Published by Cancer Network on August 4, 2026 3:00 PM

Read Original